U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2018 Forecasts Emerging Technologies and Competitive Strategies

DALLAS, February 25, 2015 /PRNewswire/ --

This new market research report of 430 pages is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Complete report on 2014-2018 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies is available at http://www.reportsnreports.com/reports/316678-2014-2018-us-genetic-diseases-cancer-forensic-and-paternity-molecular-diagnostic-testing-markets-country-forecasts-emerging-technologies-competitive-strategies-.html .

U.S. market overview is provided for laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment as well as five-year test volume and sales projections.  Report highlights include market shares of leading suppliers, business and technological trends in major markets, five-year test volume and sales forecasts, market shares of leading competitors, feature comparison of major analyzers, strategic profiles of leading market players and start-up firms developing innovative products as well as specific product and business opportunities for instrument and consumable suppliers.

Five-year test volume and sales projections are provided for Infectious Diseases Forensic Testing, Cancer Paternity Testing/HLA Typing, Genetic Diseases and Others. A comprehensive analysis of the sequencing market by laboratory segment as well as detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers is covered in this research.  From a product and technology review perspective, the report provides information on comparison of the major molecular diagnostic analyzers, extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods as well as worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D is covered in this report. Companies Abbott, Affymetrix, Agilent Technologies, Applied Gene Technologies, Arca/Nuvelo, Beckman Coulter/Danaher, Becton Dickinson, Biokit, BioMerieux, Bio-Rad, Biotest, Caliper, Cepheid, Decode, Diadexus, Eiken, Enzo, Exact Sciences, Fujirebio/Innogenetics, Grifols, Hologic/Gen-Probe, Illumina, Kreatech, Li-Cor Biosciences, Life Technologies/Thermo Fisher, Monogram Biosciences, Myriad Genetics, Nanogen/Elitech, Orchid CellMark, Ortho-Clinical Diagnostics, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, Shimadzu, Siemens, Sierra Molecular, Takara Bio and Tecan Group are discussed in the research. Along with these, comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application are also covered. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=316678 .

Another research on North American Laboratory Information System (LIS) Market says this regional industry is estimated to grow at a CAGR of 7.8% from 2014 to 2019. U.S. hold larger share in the laboratory information systems market, Canadian region is expected to grow at the highest CAGR of 8.3% in the forecast period. In this report, the North American laboratory information systems market has been broadly classified on the basis of products, types, components, delivery mode, and end-users. The product segment is divided into; standalone LIS, and integrated LIS. On the basis of types the market is segmented as; clinical LIS, and anatomical LIS. Based on components and delivery modes the North American LIS market is classified as; services & software and on premise, remotely-hosted, and cloud-based LIS respectively. The end-users segment includes; Clinical Diagnostic Laboratories, Hospitals, Anatomical Pathology Laboratories, Blood Banks, Molecular Diagnostic Laboratories

Anatomical pathology laboratory is the fastest growing segment is estimated to grow at the highest CAGR from 2014 to 2019. Factors such as increasing adoption of LIS technologies in Ophthalmology, surface tissue and mucosal membrane analysis, gastrointestinal tract, and vascular system, and increasing need to shift towards integrated healthcare systems are driving the growth of this market.

The North American laboratory information systems market is a competitive market with a number of market players. As of 2014, the North American laboratory information systems market is majorly dominated by Cerner Corporation, McKesson Corporation, Sunquest Information Systems, Inc. and Medical Information Technology, Inc.

New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the laboratory information systems market. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=313878 .

Explore more reports on the healthcare markets at http://www.reportsnreports.com/market-research/healthcare/ .

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/u/0/111656568937629536321/posts  

Twitter: http://twitter.com/marketsreports

Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689

RSS / Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

Contact:
Ritesh Tiwari / Siju K.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel:  +1-888-391-5441
[email protected]

SOURCE ReportsnReports